164 / 236
32. Ganong WF. The adrenalmedulla and adrenal cortex. In Review of
Medical Physiology, 22nd ed. Ganong WF (Ed). New York: McGraw-
Hill, 356–381, 2007.
33. Downie WW, Dixon JS, Lowe JR, et al. Adrenocortical suppression by
synthetic corticosteroid drugs: A comparative study of prednisolone
and betamethasone. Br J Clin Pharmacol 6:397–399, 1978.
34. Wilson AM, McFarlane LC, and Lipworth BJ. Systemic bioactivity
profiles of oral prednisolone and nebulized budesonide in adult
asthmatics. Chest 114:1022–1027, 1998.
35. LaRochelle GE Jr, LaRochelle AG, Ratner RE, and Borenstein DG.
Recovery of the hypothalamic-pituitary-adrenal (HPA) axis in pa-
tients with rheumatic diseases receiving low-dose prednisone. Am J
Med 95:258–264, 1993.
36. Warrington TP, and Bostwick JM. Psychiatric adverse effects of cor-
ticosteroids. Mayo Clin Proc 81:1361–1367, 2006.
37. Lewis DA, and Smith RE. Steroid-induced psychiatric syndromes. J
Affect Disord 5:319–332, 1983.
38. Acute adverse reactions to prednisone in relation to dosage. Clin
Pharmacol Ther 13:694–698, 1972.
39. Kershner P, and Wang-Cheng R. Psychiatric side effects of steroid
therapy. Psychosomatics 30:135–139, 1989.
40. Fink JL III. Liability claims based on drug use. Drug Intell Clin Pharm
17:667–670, 1983.
41. Crane M. The medication errors that get doctors sued. Med Econ
70:36–38, 40–41, 1993.
42. Rothschild JM, Federico FA, Gandhi TK, et al. Analysis of medication-
related malpractice claims. Arch Intern Med 162:2414–2420, 2002.
43. Nash JJ, Nash AG, Leach ME, and Poetker DM. Medical malpractice
and corticosteroid use. Otolaryngol Head Neck Surg 144:10–15, 2011.
44. Poetker DM, and Smith TL. What rhinologists and allergists should
know about the medico-legal implications of corticosteroid use: A
review of the literature. Int Forum Allergy Rhinol 2:95–103, 2012.
45. Poetker DM, Jakubowski LA, Lal D, et al. Oral corticosteroids in the
management of adult chronic rhinosinusitis with and without nasal
polyps: An evidence-based review with recommendations. Int Forum
Allergy Rhinol 3:104–120, 2013.
46. Lal D, Scianna JM, and Stankiewicz JA. Efficacy of targeted medical
therapy in chronic rhinosinusitis, and predictors of failure. Am J
Rhinol Allergy 23:396–400, 2009.
47. Subramanian HN, Schechtman KB, Hamilos DL. A retrospective
analysis of treatment outcomes and time to relapse after intensive
medical treatment for chronic sinusitis. Am J Rhinol 16:303–312, 2002.
48. Hessler JL, Piccirillo JF, Fang D, et al. Clinical outcomes of chronic
rhinosinusitis in response to medical therapy: Results of a prospec-
tive study. Am J Rhinol 21:10–18, 2007.
49. Ikeda K, Sakurada T, Suzaki Y, and Takasaka T. Efficacy of systemic
corticosteroid treatment for anosmia with nasal and paranasal sinus
disease. Rhinology 33:162–165, 1995.
50. Jankowski R, and Bodino C. Olfaction in patients with nasal polyp-
osis: Effects of systemic steroids and radical ethmoidectomy with
middle turbinate resection (nasalization). Rhinology 41:220–230,
2003.
51. Jankowski R, and Bodino C. Evolution of symptoms associated to
nasal polyposis following oral steroid treatment and nasalization of
the ethmoid–radical ethmoidectomy is functional surgery for NPS.
Rhinology 41:211–219, 2003.
52. Vaidyanathan S, Williamson P, Anderson K, and Lipworth B. Effect
of systemic steroids on humming nasal nitric oxide in chronic rhino-
sinusitis with nasal polyposis. Ann Allergy Asthma Immunol 105:
412–417, 2010.
53. Landsberg R, Segev Y, DeRowe A, et al. Systemic corticosteroids for
allergic fungal rhinosinusitis and chronic rhinosinusitis with nasal
polyposis: A comparative study. Otolaryngol Head Neck Surg 136:
252–257, 2007.
54. Damm M, Jungehulsing M, Eckel HE, et al. Effects of systemic steroid
treatment in chronic polypoid rhinosinusitis evaluated with magnetic
resonance imaging. Otolaryngol Head Neck Surg 120:517–523, 1999.
55. van Camp C, and Clement PA. Results of oral steroid treatment in
nasal polyposis. Rhinology 32:5–9, 1994.
56. Tuncer U, Soylu L, Aydogan B, et al. The effectiveness of steroid
treatment in nasal polyposis. Auris Nasus Larynx 30:263–268, 2003.
57. Rasp G, Kramer MF, Ostertag P, and Kastenbauer E. A new system
for the classification of ethmoid polyposis. Effect of combined local
and systemic steroid therapy. Laryngorhinootologie 79:266–272,
2000.
58. Blomqvist EH, Lundblad L, Anggard A, et al. A randomized con-
trolled study evaluating medical treatment versus surgical treatment
in addition to medical treatment of nasal polyposis. J Allergy Clin
Immunol 107:224–228, 2001.
59. Benitez P, Alobid I, de Haro J, et al. A short course of oral prednisone
followed by intranasal budesonide is an effective treatment of severe
nasal polyps. Laryngoscope 116:770–775, 2006.
60. Alobid I, Benitez P, Pujols L, et al. Severe nasal polyposis and its
impact on quality of life. The effect of a short course of oral steroids
followed by long-term intranasal steroid treatment. Rhinology 44:8–
13, 2006.
61. Kroflic B, Coer A, Baudoin T, and Kalogjera L. Topical furosemide
versus oral steroid in preoperative management of nasal polyposis.
Eur Arch Otorhinolaryngol 263:767–771, 2006.
62. Van Zele T, Gevaert P, Holtappels G, et al. Oral steroids and doxy-
cycline: Two different approaches to treat nasal polyps. J Allergy Clin
Immunol 125:1069–1076, 2010.
63. Hissaria P, Smith W, Wormald PJ, et al. Short course of systemic
corticosteroids in sinonasal polyposis: A double-blind, randomized,
placebo-controlled trial with evaluation of outcome measures. J Al-
lergy Clin Immunol 118:128–133, 2006.
64. Vaidyanathan S, Barnes M, Williamson P, et al. Treatment of chronic
rhinosinusitis with nasal polyposis with oral steroids followed by
topical steroids: A randomized trial. Ann Intern Med 154:293–302,
2011.
65. Kirtsreesakul V, Wongsritrang K, Ruttanaphol S. Clinical efficacy of
a short course of systemic steroids in nasal polyposis. Rhinology
49:525–532, 2011.
66. Sieskiewicz A, Olszewska E, Rogowski M, and Grycz E. Preoperative
corticosteroid oral therapy and intraoperative bleeding during func-
tional endoscopic sinus surgery in patients with severe nasal polyp-
osis: A preliminary investigation. Ann Otol Rhinol Laryngol 115:490–
494, 2006.
67. Wright ED, and Agrawal S. Impact of perioperative systemic steroids
on surgical outcomes in patients with chronic rhinosinusitis with
polyposis: Evaluation with the novel perioperative sinus endoscopy
(POSE) scoring system. Laryngoscope 117(Suppl 115):1–28, 2007.
68. Giordano J, Darras J, Chevalier D, and Mortuaire G. Preoperative
corticosteroid treatment and nasal polyposis. Ann Otolaryngol Chir
Cervicofac 126:120–124, 2009.
69. Ocampo CJ, and Peters AT. Medical therapy as the primary modality
for the management of chronic rhinosinusitis. Allergy Asthma Proc
34:132–137, 2013.
70. Ramakrishnan VR, Kingdom TT, Nayak JV, et al. Nationwide inci-
dence of major complications in endoscopic sinus surgery. Int Forum
Allergy Rhinol 2:34–39, 2012.
71. Poetker DM, and Smith TL. What rhinologists and allergists should
know about the medico-legal implications of antibiotic use: A review
of the literature. Int Forum Allergy Rhinol 5:104–110, 2015.
e
September–October 2015, Vol. 29, No. 5
142